Anti-inflammatory effect of intravenous immunoglobulin mediated through modulation of complement activation

Clinical Reviews in Allergy and Immunology

Volumn 29, Issue 3, 2005, Pages 207-212

  Lutz, Hans U ^a   Späth, Peter J ^b  

^a ETH ZURICH   (Switzerland)

^b ZLB Behring AG   (Switzerland)

Author keywords

Complement; Complement amplification; IgG; Inflammation; IVIg; Naturally occurring antibodies

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT; IMMUNOGLOBULIN; PROTEIN;

ANTIINFLAMMATORY ACTIVITY; ATTENUATION; AUTOIMMUNE DISEASE; BIOLOGICAL ACTIVITY; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; DERMATOMYOSITIS; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; HUMAN; IMMUNOMODULATION; INFLAMMATION; REVIEW;

ANIMALS; COMPLEMENT ACTIVATION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFLAMMATION; MODELS, IMMUNOLOGICAL;

EID: 29944443463     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1385/CRIAI:29:3:207     Document Type: Review

References (36)

1. Kazatchkine, M. D. and Kaveri, S. V. (2001), N Engl J Med 345, 747-755.
2. Sewell, W. A. and Jolles, S. (2002), Immunology 107, 387-393.
3. Dalakas, M. C. (1998), Neurology 51, S37-S45.
4. Dalakas, M. C. (2002), Neurology 59, S13-S21.
5. Stahl, G. L., Xu, Y., Hao, L., et al. (2003), Am J Pathol 162, 449-455.
6. Harboe, M., Ulvund, G., Vien, L., Fung, M., and Mollnes, T. E. (2004), Clin Exp Immunol 138, 439-446.
7. Pangburn, M. K. and Muller-Eberhard, H. J. (1980), J Exp Med 152, 1102-1114.
8. Pangburn, M. K. (1983), Fed Proc 42, 139-143.
9. Pangburn, M. K., Pangburn, K. L. W., Koistinen, V., Meri, S., and Sharma, A. K. (2000), J Immunol 164, 4742-4751.
10. Lutz, H. U. and Jelezarova, E. (2006), Mol Immunol 43, 2-12.
11. Jelezarova, E., Luginbuehl, A., and Lutz, H. U. (2003), J Biol Chem 278, 51,806-51,812.
12. Lutz, H. U., Stammler, P., Jelezarova, E., Nater, M., and Späth, P. J. (1996), Blood 88, 184-193.
13. Jelezarova, E., Vogt, A., and Lutz, H. U. (2000), Biochem J 349, 217-223.
14. Gadd, K. J. and Reid, K. B. M. (1981), Biochem J 195, 471-480.
15. Fries, L. F., Gaither, T. A., Hammer, C. H., and Frank, M. M. (1984), J Exp Med 160, 1640-1655.
16. Takata, Y., Tamura, N., and Fujita, T. (1984), J Immunol 132, 2531-2537.
17. Vidarte, L., Pastor, C., Mas, S., et al. (2001), J Biol Chem 276, 38,217-38,223.
18. Lutz, H. U., Stammler, P., and Fasler, S. (1993), J Biol Chem. 268, 17,418-17,426.
19. Schenkein, H. A. and Ruddy, S. (1981), J Immunol 126, 7-10.
20. Winkelstein, J. A. and Shin, H. S. (1974), J Immunol 112, 1635-1642.
21. Nelson, B. and Ruddy, S. (1979), J Immunol 122, 1994-1999.
22. Lutz, H. U., Nater, M., and Stammler, P. (1993), Immunology 80, 191-196.
23. Kulics, J., Rajnavölgyi, E., Füst, G., and Gergely, J. (1983), Mol Immunol 20, 805-810.
24. Jacobs, R. J. and Reichlin, M. (1983), J Immunol 130, 2775-2781.
25. Zhang, M. X., Cutler, J. E., Han, Y. M., and Kozel, T. R. (1998) Infect Immun 66, 6027-6029.
26. Basta, M., Van Goor, F., Luccioli, S., et al. (2003), Nat Med 9, 431-438.
27. Woolhiser, M. R., Brockow, K., and Metcalfe, D. D. (2004), Clin Immunol 110, 172-180.
28. Ward, P. A. (2004), Nat Rev Immunol 4, 133-142.
29. Basta, M., Kirshom, P., Frank, M. M., and Fries, L. F. (1989), J Clin Invest 84, 1974-1981.
30. Basta, M. and Dalakas, M. C. (1994), J Clin Invest 94, 1729-1735.
31. Basta, M., Ilia, I., and Dalakas, M. C. (1996), J Neuroimmunol 71, 227-229.
32. Lutz, H. U., Stammler, P., Bianchi, V., et al. (2004), Blood 103, 465-472.
33. Lutz, H. U., Bussolino, F., Flepp, R., et al. (1987), Proc Natl Acad Sci USA 84, 7368-7372.
34. Lutz, H. U., Fasler, S., Stammler, P., Bussolino, F., and Arese, P. (1988), Blood Cells 14, 175-195.
35. Price, J. F., Williams, B. D., and Challacombe, S. J. (1975), Nature (London) 257, 146-147.
36. Jelezarova, E. and Lutz, H. U. (2005), Mol Immunol 42, 1393-1403.